The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Acalabrutinib versus rituximab plus idelalisib or bendamustine in relapsed/refractory chronic lymphocytic leukemia: ASCEND results at 4 years of follow-up.
 
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; Debiopharm Group; Epizyme; Janssen-Cilag; Roche
Research Funding - Acerta Pharma; Bayer; BeiGene; Debiopharm Group; Epizyme; Incyte; Janssen-Cilag; MEI Pharma; Morphosys; Roche; Sandoz-Novartis; Takeda; TG Therapeutics; TG Therapeutics
 
Andrzej Pluta
Speakers' Bureau - Kedrion Biopharma
 
Malgorzata Wach
No Relationships to Disclose
 
Daniel Lysak
Consulting or Advisory Role - AbbVie; AstraZeneca; Janssen; Novartis
 
Martin Simkovic
Employment - University Hospital Hradec Kralove
Stock and Other Ownership Interests - AbbVie; Gilead Sciences; Johnson & Johnson; Lilly; Merck; Novartis
Honoraria - AbbVie; AstraZeneca; Gilead Sciences; Janssen-Cilag; Roche
Consulting or Advisory Role - AbbVie; AstraZeneca; Janssen-Cilag
Research Funding - Janssen
Travel, Accommodations, Expenses - Janssen
 
Iryna Kriachok
Consulting or Advisory Role - Abbvie; Bayer; Janssen; MSD; Pfizer; Roche; Takeda
Speakers' Bureau - AbbVie; Bayer; Janssen; MSD; Pfizer; Roche; Takeda
Research Funding - AbbVie; Bayer; BeiGene; Dr. Reddy's; Janssen; Merck
Expert Testimony - AbbVie; Bayer; Janssen; MSD; Pfizer; Roche; Takeda
 
Árpád Illés
Consulting or Advisory Role - Celgene; Janssen; Novartis; Pfizer; Roche; Takeda
Research Funding - Seagen; Takeda
Travel, Accommodations, Expenses - Janssen; Novartis; Pfizer; Roche
 
Javier De La Serna
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen
Speakers' Bureau - Abbvie; AstraZeneca; Janssen
Travel, Accommodations, Expenses - Abbvie; AstraZeneca
 
Sean Dolan
No Relationships to Disclose
 
Philip Campbell
No Relationships to Disclose
 
Gerardo Musuraca
Honoraria - Incyte; Janssen; Roche
Consulting or Advisory Role - Incyte; Janssen Scientific Affairs; Roche
 
Abraham Jacob
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline
Honoraria - AbbVie; AstraZeneca
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca
Research Funding - AstraZeneca
 
Eric Joseph Avery
Stock and Other Ownership Interests - Macrogenics; Moderna Therapeutics
Consulting or Advisory Role - AstraZeneca; Janssen Biotech
Research Funding - Lilly
Travel, Accommodations, Expenses - AstraZeneca
 
Jae Hoon Lee
No Relationships to Disclose
 
Ganna Usenko
Honoraria - AbbVie; Pfizer
Consulting or Advisory Role - AbbVie; Ascentage Pharma; AstraZeneca; Bayer; IL-Yang Pharm; Janssen; Karyopharm Therapeutics; Oncopeptides; Pfizer; Takeda; Telios; UCB
 
Min Hui Wang
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ting Yu
Employment - AstraZeneca
Stock and Other Ownership Interests - Abbott; AbbVie; AstraZeneca; Johnson & Johnson
 
Paolo Ghia
Honoraria - Abbvie; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; ArQule; BeiGene; Dynamo Therapeutics; Gilead Sciences; Janssen Oncology; Juno Therapeutics; Juno/Celgene/Bristol-Myers Squibb; Lilly; MEI Pharma; MSD; Roche; Sunesis Pharmaceuticals
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; ArQule; BeiGene; Dynamo Therapeutics; Gilead Sciences; Janssen; Juno Therapeutics; Lilly; MEI Pharma; MSD; Roche; Sunesis Pharmaceuticals
Research Funding - Abbvie; AstraZeneca; Gilead Sciences; Janssen Oncology; Novartis; Sunesis Pharmaceuticals